Literature DB >> 25795719

Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia.

Daisuke Araki1, Megan Othus2, Roland B Walter3, Vicky Sandhu4, Brenda M Sandmaier5, Pamela S Becker3, Frederick R Appelbaum5, Elihu H Estey6.   

Abstract

Entities:  

Keywords:  1st CR duration; prior allogeneic transplant; relapsed AML

Mesh：

Substances：

Year:  2015        PMID： 25795719      PMCID： PMC4486235          DOI： 10.3324/haematol.2014.118570

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

1.  Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission.

Authors:  Alan K Burnett; Anthony Goldstone; Robert K Hills; Donald Milligan; Archie Prentice; John Yin; Keith Wheatley; Ann Hunter; Nigel Russell
Journal:  J Clin Oncol       Date:  2013-02-25       Impact factor: 44.544

2.  Prognostic index for adult patients with acute myeloid leukemia in first relapse.

Authors:  Dimitri A Breems; Wim L J Van Putten; Peter C Huijgens; Gert J Ossenkoppele; Gregor E G Verhoef; Leo F Verdonck; Edo Vellenga; Georgine E De Greef; Emanuel Jacky; Johannes Van der Lelie; Marc A Boogaerts; Bob Löwenberg
Journal:  J Clin Oncol       Date:  2005-01-04       Impact factor: 44.544

3.  Reduced mortality after allogeneic hematopoietic-cell transplantation.

Authors:  Ted A Gooley; Jason W Chien; Steven A Pergam; Sangeeta Hingorani; Mohamed L Sorror; Michael Boeckh; Paul J Martin; Brenda M Sandmaier; Kieren A Marr; Frederick R Appelbaum; Rainer Storb; George B McDonald
Journal:  N Engl J Med       Date:  2010-11-25       Impact factor: 91.245

Review 4.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

Review 5.  Hematopoietic cell transplantation in first complete remission versus early relapse.

Authors:  Frederick R Appelbaum; S Frieda Pearce
Journal:  Best Pract Res Clin Haematol       Date:  2006       Impact factor: 3.020

Review 6.  Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

Authors:  John Koreth; Richard Schlenk; Kenneth J Kopecky; Sumihisa Honda; Jorge Sierra; Benjamin J Djulbegovic; Martha Wadleigh; Daniel J DeAngelo; Richard M Stone; Hisashi Sakamaki; Frederick R Appelbaum; Hartmut Döhner; Joseph H Antin; Robert J Soiffer; Corey Cutler
Journal:  JAMA       Date:  2009-06-10       Impact factor: 56.272
  6 in total
  1 in total

1.  Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience.

Authors:  Chezi Ganzel; Zhuoxin Sun; Larry D Cripe; Hugo F Fernandez; Dan Douer; Jacob M Rowe; Elisabeth M Paietta; Rhett Ketterling; Michael J O'Connell; Peter H Wiernik; John M Bennett; Mark R Litzow; Selina M Luger; Hillard M Lazarus; Martin S Tallman
Journal:  Am J Hematol       Date:  2018-08       Impact factor: 13.265
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.